Virpax Pharmaceuticals Correlations

VRPX Stock  USD 0.76  0.05  7.04%   
The current 90-days correlation between Virpax Pharmaceuticals and Hoth Therapeutics is -0.02 (i.e., Good diversification). The correlation of Virpax Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Virpax Pharmaceuticals Correlation With Market

Average diversification

The correlation between Virpax Pharmaceuticals and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virpax Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.

Moving together with Virpax Stock

  0.72VALN Valneva SE ADRPairCorr
  0.74VCNX Vaccinex Earnings Call TodayPairCorr
  0.7DRMA Dermata TherapeuticsPairCorr
  0.64DYAI Dyadic InternationalPairCorr
  0.75VNDA Vanda PharmaceuticalsPairCorr
  0.71VRCA Verrica PharmaceuticalsPairCorr
  0.66CDTTW Conduit PharmaceuticalsPairCorr
  0.73VTGN VistaGen TherapeuticsPairCorr

Moving against Virpax Stock

  0.76DMAC DiaMedica Therapeutics Earnings Call TodayPairCorr
  0.55DOMH Dominari HoldingsPairCorr
  0.47VCYT VeracytePairCorr
  0.44DNLI Denali TherapeuticsPairCorr
  0.35VERA Vera TherapeuticsPairCorr
  0.31DSGN Design Therapeutics Earnings Call TodayPairCorr
  0.69VRDN Viridian Therapeutics Earnings Call TodayPairCorr
  0.59VRNA Verona Pharma PLCPairCorr
  0.45VSTM Verastem Buyout TrendPairCorr
  0.32VKTX Viking TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Virpax Stock performing well and Virpax Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Virpax Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Virpax Pharmaceuticals Corporate Management